30 Participants Needed

Virtual Counseling for Tobacco Addiction

AE
HH
Overseen ByHeidi Hutton, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help people quit smoking by testing a virtual counseling program combined with community health worker support. Participants will receive a computerized intervention called C-Raven (an avatar-delivered computerized intervention for tobacco cessation) and guidance on lung cancer screening. The control group will wait six months before accessing the intervention. This study focuses on individuals living in low-income housing in Baltimore who have smoked more than 100 cigarettes in their lifetime and are considering quitting. Participants must speak English and plan to stay in their current home for nine months. As a Phase 4 trial, this research involves an FDA-approved treatment that has proven effective, aiming to understand how it benefits more patients.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using medication to help quit smoking.

What is the safety track record for C-Raven?

Research shows that virtual programs like C-Raven, which help people quit smoking, are generally safe and easy to use. In past studies, treatments similar to C-Raven were tested and showed good results without major safety issues. Participants in these studies had positive experiences with the virtual counselor, who supported them in quitting smoking, along with help from community health workers.

Additionally, the nicotine replacement therapies included in the C-Raven program have been safely used for a long time to help people stop smoking. This combination of virtual counseling and nicotine aids is designed to be both effective and safe.

Since this trial is in a later stage, earlier studies have already checked C-Raven for safety. This stage usually focuses more on effectiveness rather than finding new safety problems. While no treatment is completely without risk, the evidence so far suggests that C-Raven is a safe choice for those wanting to quit smoking.12345

Why are researchers enthusiastic about this study treatment?

Researchers are excited about the virtual counseling for tobacco addiction because it offers a unique blend of personalized support and technology. Unlike traditional methods like nicotine replacement therapy or face-to-face counseling, this approach combines virtual counseling with community health worker support, making it more accessible and potentially more engaging. Additionally, it incorporates shared decision-making around lung cancer screening, which empowers participants and may enhance their commitment to quitting smoking. This comprehensive, tech-driven method could provide a more flexible and supportive path to cessation, reaching individuals who might not otherwise engage with traditional treatment options.

What evidence suggests that the C-Raven intervention is effective for tobacco cessation?

Studies have shown that virtual counseling can significantly help people quit smoking. Research indicates that a digital program called "Happy Ending" helped 22.3% of participants remain smoke-free long-term. In this trial, one group will receive C-Raven, the treatment under study, which is also a virtual program and includes support from community health workers. This combination aims to make quitting smoking easier and more successful. Although specific data on C-Raven's success is not yet available, it employs a similar approach to other effective digital programs.13678

Who Is on the Research Team?

AE

Alejandra Ellison-Barnes, MD

Principal Investigator

Johns Hopkins School of Medicine

Are You a Good Fit for This Trial?

This trial is for individuals living in low-income housing units in Baltimore who are struggling with tobacco addiction or use disorder. Participants should be interested in quitting smoking and willing to engage with a virtual cessation program and potentially receive lung cancer screening.

Inclusion Criteria

Planning to remain in current housing unit for 9 months
Considering smoking cessation
I am over 50 and have smoked more than 100 cigarettes in my life.

Exclusion Criteria

Investigator discretion
Current engagement in formal smoking cessation program
Major psychiatric impairment
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (virtual or in-person)

Baseline Assessment

Initial evaluation including demographics, clinical history, and tobacco use history

1 day
1 visit (in-person)

Treatment

Participants receive a virtual counselor intervention for smoking cessation and nicotine replacement therapies

12 weeks
2 visits (in-person), up to 24 remote follow-ups

Follow-up

Participants are monitored for smoking cessation outcomes and intervention acceptability

6 months
Assessments at 1, 3, and 6 months

What Are the Treatments Tested in This Trial?

Interventions

  • C-Raven
Trial Overview The study tests a computerized, avatar-led tobacco cessation counseling called C-Raven, supplemented by community health worker support. It compares this approach against waiting for treatment. The effectiveness of the intervention and its implementation will be measured over six months.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: C-Raven + CHW Smoking Cessation InterventionExperimental Treatment4 Interventions
Group II: No InterventionActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

Walgreens

Collaborator

Trials
1
Recruited
30+

Maryland Cigarette Restitution Fund

Collaborator

Trials
10
Recruited
900+

Walgreens

Industry Sponsor

Trials
4
Recruited
3,100+

Published Research Related to This Trial

A qualitative analysis of 742 counseling messages from 270 smokers revealed that the most common theme was 'Support and Strategies for Quitting,' indicating that smokers actively seek guidance and encouragement during their cessation journey.
The study highlights the effectiveness of asynchronous online counseling as a supportive tool for smokers, providing a platform for sharing experiences and strategies throughout the quitting process.
Exploring Online Asynchronous Counseling With Tobacco Treatment Specialists in the QUIT-PRIMO and National Dental PBRN HI-QUIT Studies: Who Uses It and What Do They Say?Williams, JH., DeLaughter, K., Volkman, JE., et al.[2019]
In a study involving 725 smokers over a 6-month period, only 33.8% engaged with a trained tobacco treatment specialist (TTS) through asynchronous messaging, indicating low participant engagement.
Despite the feasibility of using asynchronous counseling to provide evidence-based support, there was no significant association between the frequency of TTS communication and smoking cessation outcomes, suggesting that future research should focus on increasing engagement and combining this method with other cessation strategies.
Secure Asynchronous Communication Between Smokers and Tobacco Treatment Specialists: Secondary Analysis of a Web-Assisted Tobacco Intervention in the QUIT-PRIMO and National Dental PBRN Networks.Sadasivam, RS., Kamberi, A., DeLaughter, K., et al.[2020]
The pilot study demonstrated that an Internet-based virtual reality program for smoking cessation was acceptable and effective for rural teens, involving seven 1-hour chat sessions over two months with a trained counselor.
Participants showed significant improvements in quitting behaviors, including reduced smoking amounts and increased intentions to quit, along with positive trends in abstinence rates and quit attempts after the intervention.
Pilot test of an Internet virtual world chat room for rural teen smokers.Woodruff, SI., Edwards, CC., Conway, TL., et al.[2019]

Citations

C-Raven, a Virtual Tobacco Cessation Intervention in ...The investigators will conduct a pilot randomized controlled trial of an avatar-delivered computerized intervention for tobacco cessation and CHW support to ...
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in ...... to collect data on the feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be ...
C-Raven, a Virtual Tobacco Cessation Intervention in the ...Beschreibung: Participants will receive a virtual counselor intervention for smoking cessation, be offered the opportunity to utilize nicotine replacement ...
Virtual Counseling for Tobacco AddictionA fully automated digital smoking cessation intervention, called Happy Ending, significantly improved long-term abstinence rates among participants (22.3%) ...
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in ...To inform a future randomized trial of a virtual counselor led computer delivered intervention for tobacco cessation augmented with ...
Pilot Testing a Computer Delivered Tobacco Cessation ...To this end, the investigators propose a two-arm randomized controlled trial, randomizing up to 90 individuals with tobacco use to the current CRAVEN program ...
Testing C-Raven, a Virtual Tobacco Cessation - ClinConnectTo inform a future randomized trial of a virtual counselor led computer delivered intervention for tobacco cessation augmented with community health worker ...
Conversational artificial intelligence interventions to support ...We found limited but promising evidence on the effectiveness of conversational artificial intelligence interventions for tobacco cessation.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security